Journey Medical Corp (DERM) Gross margin 2020–2025
Journey Medical Corp (DERM) gross margin by fiscal year — reported gross profit divided by reported revenue.
65.8%FY2025 · since FY2020: 67.2% → 65.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 65.8% | +3.7 pp |
| FY2024 | 62.1% | +0.5 pp |
| FY2023 | 61.6% | +5.0 pp |
| FY2022 | 56.7% | +7.5 pp |
| FY2021 | 49.2% | -18.0 pp |
| FY2020 | 67.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DERM financial trends
DERM RevenueDERM Net incomeDERM Net marginDERM Gross profitDERM Operating incomeDERM Operating marginDERM Operating cash flowDERM Free cash flowDERM Capital expendituresDERM Return on equityDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Total liabilitiesDERM Shareholders’ equityDERM overview →